Depressive symptoms and 10-year risk for cardiovascular morbidity and mortality

World Journal of Biological Psychiatry

Volumn 11, Issue 6, 2010, Pages 834-839

  Koponen, Hannu ^a   Jokelainen, Jari ^b,c   Keinnen Kiukaanniemi, Sirkka ^b,c   Vanhala, Mauno ^d,e  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d Central Hospital of Middle Finland   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Beck Depression Inventory; Cardiovascular event; Framingham; Mortality; Risk function; SCORE risk function

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CARDIOVASCULAR RISK; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; RISK ASSESSMENT; SYMPTOM;

CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77955626785     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.486842     Document Type: Article

References (39)

1. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. 2005. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications. J Clin Endocrinol Metab 90:2522-2530.
2. Barth J, Schumacher M, Herrman-Lingen C. 2004. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med 66:802-813.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
4. Bonnet F, Irving K, Terra J-L, Nony P, Bertheneze F, Moulin P. 2005. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertension 23:611-617.
5. Bremmer MA, Hoogendijk WJ, Deeg DJ, Schoevers RA, Schalk BW, Beekman AT. 2006. Depression in older age is a risk factor for first ischemic cardiac events. Am J Geriatr Psychiatry 14:523-530.
6. Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ et al. 2008. Depressive symptoms and metabolic syndrome: Is inflammation an underlying link? Biol Psychiatry 64:896-900.
7. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. 2003. Estimation of ten-year risk of fatal cardiovascular risk in Europe: the SCORE project. Eur Heart J 24:987-1003.
8. Cuijpers P, Smit F. 2002. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 72:227-236.
9. Dimsdale JE. 2008. Psychological stress and cardiovascular disease. J Am Coll Cardiol 51:1237-1246.
10. Everson-Rose SA, House JS, Mero RP. 2004. Depressive symptoms and mortality risk in a national sample: confounding effects of health status. Psychosom Med 66:823-830.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 285:2486-2497.
12. Ferketich AK, Ferguson JP, Binkley PF. 2005. Depressive symptoms and inflammation among heart failure patients. Am Heart J 150:132-136.
13. Grundy SM, Cleeman JI, Daniels SRA, Donato KA, Eckel RH, Franklin BA, et al. 2005. Diagnosis and management of the metabolic syndrome: An American Heart Association/National heart, lung, and blood institute scientific statement: executive summary. Circulation 112:e285-290.
14. Gump BB, Matthews KA, Eberly LE, Chang Y-F, for the MRFTT Group. 2005. Depressive symptoms and mortality in men. Results from the multiple risk factor intervention trial. Stroke 36:98-102.
15. Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA. 2009. No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr Scand 120:14-22.
16. Hu G, Qiap Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyörälä K, for the DECODE study group. 2004. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164:1066-1076.
17. Hunt KJ, Williams K, Hazuda HP, Stern MP, Haffner SM. 2007. The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: The San Antonio heart study. Ann Epidemiol 17:870-877.
18. Jasti S, Dudley WN, Goldwater F. 2008. SAS macros for testing statistical mediation in data with binary mediators or outcomes. Nurs Res 57:118-122.
19. Kamphuis MH, Geerlings MI, Giampaoli S, Nissinen A, Grobbee DE, Kromhout D. 2009. The association of depression with cardiovascular mortality is partly explained by health status. The FINE study. J Affect Disord 114:184-192.
20. Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M. 2008. Metabolic syndrome predisposes to depression. A population-based 7-year follow-up study. J Clin Psychiatry 69:178-182.
21. Lasa L, Ayoso-Mateos JL, Vasquez-Barquero JL, Diez-Manrique FJ, Dowrick CF. 2000. The use of the Beck Depression Inventory to screen depression in the general population: a preliminary analysis. J Affect Disord 57:261-265.
22. Lorenzo C, Willliams K, Hunt KJ, Haffner SM. 2007. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30:8-13.
23. Malik S, Wong ND, Franklin SS, Kamath TV, L ' Italien GJ, Rio JR, et al. 2004. Impact of metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in the United States adults. Circulation 110:1245-1250.
24. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. 2005. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28:385-390.
25. Ovaskainen Y, Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M. 2009. Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin1 receptor antagonist levels in males. Psychiatry Res 167:73-79.
26. Ramasubbu R. 2002. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypothesis 59:537-551.
27. Steer RA, Ball R, Ranieri WF, Beck AT. 1999. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 55:117-128.
28. Stewart RAH, North FM, West TM, Sharples KJ, Simes RJ, Colquhoun DM, et al. 2003. Depression and cardiovascular mortality: cause or consequence. Eur Heart J 24:2027-2037.
29. Surtees PG, Wainwright NWJ, Luben RN, Wareham NJ, Bingham SA, Khaw K-T. 2008. Depression and ischemic heart disease mortality: evidence from the EPC-Norfolk United Kingdom prospective cohort study. Am J Psychiatry 165:515-523.
30. Thorndike AN, Rigotti NA. 2009. A tragic triad: coronary artery disease, nicotine addiction, and depression. Curr Opin Cardiol 24:447-453.
31. Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow VB, Keinänen-Kiukaanniemi S. 2005. Insulin resistance and depression: cross-sectional study. Br Med J 330: 17-18. (Pubitemid 40070469)
32. Tzoulaki I, Liberopoulos G, Ioannidis JPA. 2009. Assessment of claims of improved prediction beyond the Framingham risk score. J Am Med Assoc 302:2345-2352.
33. Vaccarino V, Johnson BD, Sheps DS, Reis SE, Kelsey SF, Bittner V, et al. 2007. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia. J Am Coll Cardiol 50:2044-2050.
34. Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, et al. 2008. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 70:40-48.
35. Vanhala M, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Koponen H. 2009. Depressive symptoms predispose females to metabolic syndrome. A 7-year follow-up study. Acta Psychi-atr Scand 119:137-142.
36. Vanhala P, Vanhala M, Kumpusalo E, Keinänen-Kiukaanniemi S. 2002. The quantitative insulin sensitivity check index QUICKI predicts the onset of type 2 diabetes better than fasting plasma insulin in obese subjects; a 5-year follow-up study. J Clin Endo-crinol Metab 87:5834-5837.
37. Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J. 2007. The metabolic syndrome predicts cardiovascular mortality: a 13-yer follow-up study in elderly non-diabetic Finns. Eur Heart J 28:857-864. (Pubitemid 47351113)
38. Wilson PW, D ' Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. 1998. Prediction of coronary heart disease using risk categories. Circulation 97:1837-1847.
39. Wulsin LR, Singal BM. 2003. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 65:201-210.